UCB | Indtjening Pr



Fiscal Kalender Actual Konsensus Forrige Dato
FY2024H2 Dec/2024 2.89 1.57 Feb/28 2025
FY2024H1 Jun/2024 2.09 1.81B 2.63 Jul/25 2024
FY2023H2 Dec/2023 1.57 1.22 Feb/28 2024
FY2023H1 Jun/2023 2.63 1.74 3.15 Jul/27 2023
FY2022H2 Dec/2022 1.22 1.04 3.09 Feb/22 2023
FY2022H1 Jun/2022 3.15 2.48 3.4 Jul/28 2022
FY2021H2 Dec/2021 3.09 2.66 2.59 Feb/24 2022
FY2021H1 Jun/2021 3.4 2.97 2.77 Jul/29 2021
FY2020H2 Dec/2020 2.59 2.16 2.78 Feb/25 2021
FY2020H1 Jun/2020 2.77 2.87 2.42 Jul/27 2020
FY2019H2 Dec/2019 2.78 2.53 1.7 Feb/20 2020
FY2019H1 Jun/2019 2.42 2.51 3.09 Jul/25 2019

Eps Lave om Dato
Alcon AG USD 0.72 0.09 2024-12
Almirall EUR -0.02 0.18 2024-12
Amarin USD -0.06 0.06 2024-09
argenx SE USD 11.22 9.94 2024-12
AstraZeneca USD 2.09 0.01 2024-12
Bayer EUR 1.05 0.81 2024-12
Galapagos EUR -0.39 0.19 2024-12
Genmab DKK 59.49 39.55 2024-12
GlaxoSmithKline GBP 0.23 0.27 2024-12
GRIFOLS EUR 0.22 0.06 2024-12
Hikma Pharmaceutical USD 0.6 0.41 2024-12
Lonza CHF 7.99 0.97 2024-12
Merck EUR 2.07 0.23 2024-12
Novartis USD 1.98 0.4 2024-12
Orion EUR 0.52 0.62 2024-12
Recordati EUR 0.37 0.17 2024-12
Roche Holding CHF 8.57 1.66 2024-12
Sanofi EUR 1.31 1.55 2024-12
UCB EUR 2.89 0.8 2024-12
Unibail Rodamco EUR 4.71 0.43 2024-12



UCB Indtjening Pr - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.